{"id":24703,"date":"2025-07-29T07:28:48","date_gmt":"2025-07-29T11:28:48","guid":{"rendered":"https:\/\/medicarereport.org\/?p=24703"},"modified":"2025-07-29T07:28:50","modified_gmt":"2025-07-29T11:28:50","slug":"how-health-systems-are-preparing-for-a-potential-340b-overhaul","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=24703","title":{"rendered":"How health systems are preparing for a potential 340B overhaul"},"content":{"rendered":"\n<p>(By: Alexandra Murphy for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n\n\n\n<p>As federal scrutiny and legislative proposals continue around the 340B drug pricing program, health systems are stepping up advocacy efforts and preparing for potential disruptions.<\/p>\n\n\n\n<p>At St. Louis-based Ascension, one of the nation\u2019s largest Catholic health systems, Chief Pharmacy Officer Michael Wascovich, PharmD, said leaders are monitoring developments that could change the way safety-net hospitals access and use discounted drugs.  Continue reading<a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/how-health-systems-are-preparing-for-a-potential-340b-overhaul\/\" data-type=\"link\" data-id=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/how-health-systems-are-preparing-for-a-potential-340b-overhaul\/\"> here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"100\" class=\"wp-image-10021\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost.jpg\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost.jpg 2121w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-300x200.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-768x512.jpg 768w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-1024x683.jpg 1024w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>\u00a0The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By: Alexandra Murphy for Becker&#8217;s Hospital Review) As federal scrutiny and legislative proposals continue around the 340B drug pricing program,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,20,10,15],"tags":[433,385,238,884,65],"class_list":["post-24703","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-health-care-redesign","category-legislative-update","category-part-dprescription-drugs","tag-340b-drug-discount-program","tag-healthcare-costs","tag-healthcare-finance","tag-healthcare-redesign","tag-medicare-part-d"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/24703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24703"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/24703\/revisions"}],"predecessor-version":[{"id":24704,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/24703\/revisions\/24704"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}